NeuroCampus Aarhus (NCA) is a non-funded cross-disciplinary research network at Aarhus University and Aarhus University Hospital open for all interested in the brain.
New research-based knowledge is needed to enable us to develop the medicine and treatment principles of the future. This knowledge can contribute to reducing the consequences of the diseases for individuals, families and society.
NCA strives to understand the function of the normal brain and the changes which take place in connection with diseases such as psychiatric disorders, strokes, neurodegenerative diseases such as Alzheimer's and Parkinson's disease, movement disorders and traumatic brain injury. The brain and the nervous system are extremely complicated research fields. Advanced equipment and highly-specialised researchers and clinicians from a wide range of research areas are required to investigate how billions of nerve cells communicate with each other via the nerve cells communication system – the synapses.
NCA covers research areas ranging from nanotechnology over basic and clinical neuroscience to rehabilitation and cognitive neuroscience. NCA's interdisciplinary networks combine research and treatment within a common frame of reference – regardless of whether this research takes place at the molecular, cellular or system level. This synergy makes it possible to investigate the myriad of damage- and repair mechanisms which are found on all levels in connection with diseases of the brain.
Currently, the number of stakeholders exceeds more than 400 persons.
The NCA Steering Committee consists of nine people from basic and clinical research. Learn more here.
It is the vision of NeuroCampus Aarhus and Aarhus University to be international research leaders within neuroscience from molecules, cells and animal models to healthy individuals and patients with psychiatric and neurological diseases.Access the full text "NeuroCampus Aarhus - Vision og strategi for neurovidenskabelig forskning ved Aarhus Universitet" via the link (only in Danish).